132970-18-4 Usage
Uses
Used in Chemical Synthesis:
(2S)-2-[(tert-butoxycarbonyl)amino]-2-methyl-3-(3,4-dimethoxyphenyl)propanoic acid is used as a key intermediate in chemical synthesis for the development of complex organic molecules. Its unique structure allows for versatile reactions and modifications, facilitating the creation of a wide range of chemical entities.
Used in Drug Development:
In the pharmaceutical industry, (2S)-2-[(tert-butoxycarbonyl)amino]-2-methyl-3-(3,4-dimethoxyphenyl)propanoic acid is utilized as a starting material or a component in drug development. Its incorporation into drug candidates can lead to the discovery of new therapeutic agents with specific targets and mechanisms of action, contributing to the advancement of medicine.
Used in Biotechnology:
(2S)-2-[(tert-butoxycarbonyl)amino]-2-methyl-3-(3,4-dimethoxyphenyl)propanoic acid is also employed in the biotechnology sector, where it can be engineered into biopolymers or used to create novel bioactive molecules. Its potential applications in this field include the development of new biopharmaceuticals, diagnostic tools, and therapeutic agents.
Used in Research and Development:
This amino acid derivative is used in research and development laboratories to explore its chemical properties and potential interactions with biological systems. Understanding its reactivity and behavior can lead to innovative applications and the design of new molecules with specific functions in various scientific and medical fields.
Check Digit Verification of cas no
The CAS Registry Mumber 132970-18-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,9,7 and 0 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 132970-18:
(8*1)+(7*3)+(6*2)+(5*9)+(4*7)+(3*0)+(2*1)+(1*8)=124
124 % 10 = 4
So 132970-18-4 is a valid CAS Registry Number.
132970-18-4Relevant academic research and scientific papers
Enantiocatalytic activity of substituted 5-benzyl-2-(pyridine-2-yl) imidazolidine-4-one ligands
Drabina, Pavel,Karel, Sergej,Panov, Illia,Sedlak, Milos
, p. 334 - 339 (2013/04/23)
Currently, asymmetric synthesis represents one of the main streams of organic synthesis. Although an extensive research has been carried out in this area, the synthesis of chiral compounds with the required enantiomeric purity is still a challenging issue. Herein, we focus on the preparation of new enantioselective catalysts based on pyridine-imidazolidinones. The substituted 5-benzyl-2-(pyridine-2-yl)imidazolidine-4-ones 5-8 were prepared by condensation of chiral amino acid amides (α-methylDOPA and α- methylphenylalanine) with 2-acetylpyridine and pyridine-2-carbaldehyde. The individual isomers of the described ligands 5-8 were separated chromatographically. The copper(II) complexes of these chiral ligands were studied as enantioselective catalysts for the asymmetric Henry reaction of substituted aldehydes with nitromethane or nitroethane. The ligands containing a methyl group at the 2-position of the imidazolidinone ring 6a and 8a exhibit a high degree of enantioselectivity (up to 91% ee). The nitroaldols derived from nitroethane (2-nitropropan-1-ols) were obtained with a comparable enantiomeric purity to derivatives of 2-nitroethanol. This group of ligands represents a new and promising class of enantioselective catalysts, which deserve further attention.
A facile method for the side-chain protection of α-methyl-β-3,4-dihydroxyphenyl-L-alanine (αMeDopa) for solid-phase peptide synthesis
Hsieh,deMaine
, p. 59 - 62 (2007/10/02)
Two approaches have been used to prepare N(α)-tert-butoxycarbonyl-α-methyl-β-3,4-dimethoxy-, or dibenzyloxyphenyl-L-alanine, N(α)-Boc-α-MeDopa(R)2, where R is the methyl or benzyl ether. In the first approach, α-methyl-β-3,4-dihydroxyphenyl-L-a
